key: cord-0929259-bd0ts2t1
authors: Rodrigues, Jeremy; Chan, James K-K; Issa, Fadi
title: Surgery during the COVID-19 pandemic
date: 2020-11-05
journal: Lancet
DOI: 10.1016/s0140-6736(20)32280-7
sha: 013efa7e703295b75ad945d8945653ed2c84eb8c
doc_id: 929259
cord_uid: bd0ts2t1

nan

Submissions should be made via our electronic submission system at http://ees.elsevier.com/ thelancet/ www.thelancet.com Vol 396 November 7, 2020 e75

We fear that limitations of the COVIDSurg Collaborative's study 1 risk compromising patient care. Patient outcome data from patients who had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was compared with prepandemic data. This comparison is illogical because complete changes to services meant that only very urgent surgery was likely to be done during the pandemic.

Furthermore, presentation to the hospital for treatment was probably delayed, and hence a patient's clinical state might have been more severe than it would have been before the pandemic. Testing positive for SARS-CoV-2 might possibly be a confounder for the association between poor operative outcomes and suboptimal health-care provision as a result of health-care service strain during pandemic peaks. Thus, worse outcomes are expected irrespective of the positive SARS-CoV-2 status, and this limitation is not addressed by the COVIDSurg Collaborative. 1 The 1209 COVIDSurg Collaborative authors could have easily captured patient outcomes for those without COVID-19, which would have provided meaningful context. The inclusion criteria comprised of patients who had SARS-CoV-2 infection confirmed within 7 days before surgery and proceeded with surgery, presumably because of a strong clinical need, and patients with clinical deterioration 30 days after surgery who were consequently tested. Asymptomatic individuals infected by SARS-CoV-2 (estimated at 50% cases) 2 would not necessarily be tested. Hence, there is a high risk of bias towards worse outcomes.

There is pronounced heterogeneity in disease pathology and patient outcomes (30-day mortality was 0 [0%] of 268 patients for ophthalmology vs 15 [42·9%] patients for thoracic surgery), making the overarching headline misleading by stating that 30-day mortality was 23·8% (268 of 1128). The COVIDSurg Collaborative suggests that surgery should be postponed for those purportedly at high risk, which is not justified and could lead to care being denied inappropriately. This proposal is also not generalisable to resuming elective surgery under circumstances that differ to those in the studyeg, in preoperative testing, during patient isolation, and in clinical areas maintained free from COVID-19. A more appropriate discussion of the limitations and applicability of these findings is warranted.

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review

We declare no competing interests.